The CDC told state officials Sept. 2 that they should be prepared to distribute a coronavirus vaccine by Nov. 1. Kaiser’s poll, conducted from Aug. 28 to Sept. 3, examined Americans’ attitudes toward the race to develop and distribute a COVID-19 vaccine.
Here are some of its notable findings:
- Fifty-four percent of American adults said they would not want to get vaccinated if a COVID-19 vaccine gained FDA approval before the election, which is slated for Nov. 3.
- Eighty-one percent of American adults do not believe a COVID-19 vaccine will become available in the U.S. before the presidential election, with 90 percent of Democrats, 84 percent of independents and 75 percent of Republicans reporting such doubt.
- Sixty-two percent of American adults reported feeling worried that White House political pressure will cause the FDA to rush its COVID-19 vaccine approval process without making sure it’s entirely safe and effective, with 85 percent of Democrats, 61 percent of independents and 35 percent of Republicans expressing such worry.
- Thirty-nine percent of American adults believe the FDA is paying “too much attention” to politics when it comes to its coronavirus response. Forty-two percent of respondents reported feeling the same way about the CDC.
More articles on pharmacy:
8 requirements pharmacists need to meet to administer COVID-19 vaccines
USPS ‘significantly’ delayed prescription drug deliveries, Senate report says
AstraZeneca CEO suggests vaccine trial’s suspension is its 2nd, elicits transparency concerns
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
